MEDS DataMEDS AI, Inc.

0.7277USD-1.53%Mkt Cap: 4.17M USDP/E: —

DataMEDS AI, Inc. operates as a health IT company in the United States. The company focuses on the vertical integration of technology, pharmacy, pharmaceutical-adjacent, and telemedicine business units to deliver an enha…

Institutional holders15 on file

Key Statistics

Company
Market Cap4.17M USD
Enterprise Value32.44M USD
Revenue (TTM)8.02M USD
Gross Profit-6.43M USD
Net Income (TTM)-101.27M USD
Revenue/Share3.97 USD
Last Price0.7277 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees—
CountryUS
SectorHealthcare
IndustryMedical Distribution
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-0.59
EV/Revenue4.04
P/S0.52
P/B-0.12
EPS (TTM)-18.39 USD
EPS (Forward)—
52W Range
0.50481% of range33.15
52W High33.15 USD
52W Low0.5048 USD
Profitability
Gross Margin-27.54%
Oper. Margin-719.27%
EBITDA Margin0.00%
Profit Margin-433.95%
ROE813.59%
ROA-332.49%
ROIC-661.33%
ROCE-11952.35%
Growth
Revenue Growth-77.20%
Earnings Growth—
Cash Flow & Leverage
Operating CF-10.86M USD
CapEx (TTM)881.53K USD
FCF Margin29.54%
FCF Yield56.89%
Net Debt30.17M USD
Net Debt/EBITDA-0.54
Net Debt/FCF12.73
Balance Sheet
Debt/Equity-1.99
Current Ratio0.14
Quick Ratio0.09
Book Value/Sh-6.14 USD
Cash/Share0.80 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Splits
Last Split1:50
Split DateMay 26, 2026
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.5.72M
Float1.46M
Insiders44.20%
Institutions1.77%
Short Interest
Short Ratio0.1d
Short % Float8.98%
Short % Out.7.17%
Shares Short371.42K
Short (prev mo.)525.08K
Technical
SMA 502.470 (-70.5%)
SMA 2004.860 (-85.0%)
Beta—
S&P 52W Chg12.08%
Avg Vol (30d)1.50M
Avg Vol (10d)1.03M
Technical Indicators
RSI (14)28.5
MACD-0.5043
MACD Signal-0.4724
MACD Hist.-0.0319
BB Upper2.568 USD
BB Middle1.367 USD
BB Lower0.1668 USD
BB Width175.60%
ATR (14)0.3279 USD
Vol Ratio (20d)1.80x

About DataMEDS AI (NASDAQ: MEDS)

›

DataMEDS AI (NASDAQ: MEDS) is listed on Nasdaq, where its shares trade in USD. It belongs to the Medical Distribution industry, part of the Healthcare sector.

The shares were at 0.7277 USD on 19 November 2026, down 97.5% over 52 weeks. Its 52-week range is 0.5048 USD to 33.15 USD: the price is 97.8% below the high and 44.2% above the low.

Its market capitalisation is 4.17M USD.

DataMEDS AI reports revenue down 77.2% year over year.

Its debt exceeds its cash by 30.17M USD. Its Piotroski F-score is 2 out of 9, a weak reading of its financial health.